Stocks and Investing Stocks and Investing
Tue, November 1, 2022
Mon, October 31, 2022

Navin Jacob Maintained (ABBV) at Hold with Increased Target to $147 on, Oct 31st, 2022


Published on 2024-10-27 23:47:25 - WOPRAI, Navin Jacob
  Print publication without navigation


Navin Jacob of UBS, Maintained "AbbVie Inc." (ABBV) at Hold with Increased Target from $146 to $147 on, Oct 31st, 2022.

Navin has made no other calls on ABBV in the last 4 months.



There are 7 other peers that have a rating on ABBV. Out of the 7 peers that are also analyzing ABBV, 2 agree with Navin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Colin Bristow of "UBS" Maintained at Hold with Decreased Target to $146 on, Monday, August 1st, 2022
  • Luisa Hector of "Berenberg" Reiterated at Hold and Held Target at $135 on, Friday, July 15th, 2022


These are the ratings of the 5 analyists that currently disagree with Navin


  • David Risinger of "SVB Leerink" Maintained at Sell with Decreased Target to $135 on, Friday, September 30th, 2022
  • Terence Flynn of "Morgan Stanley" Reiterated at Buy and Held Target at $188 on, Wednesday, September 14th, 2022
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $155 on, Wednesday, August 24th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $155 on, Monday, August 1st, 2022
  • Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $160 on, Friday, July 29th, 2022
Contributing Sources